Literature DB >> 2672926

Surviving adult cancers. Part 2: Psychosocial implications.

D Welch-McCaffrey1, B Hoffman, S A Leigh, L J Loescher, F L Meyskens.   

Abstract

PURPOSE: To address the psychosocial implications of surviving adult cancers by a comprehensive review of the literature. DATA IDENTIFICATION: An English-language literature search using MEDLINE (1970 to 1988). Index Medicus (1970 to 1988), and bibliographic reviews of textbooks and review articles. STUDY SELECTION: Of 103 originally identified articles, 58 that specifically addressed the stated purpose were selected. DATA EXTRACTION: Four authors reviewed and critiqued the literature extrapolating the major themes on this topic. RESULTS OF DATA SYNTHESIS: There is little information on the many psychosocial variables that affect an adult's long-term cancer survival trajectory. Collation of data identified the following significant psychosocial themes: fear of recurrence and death, relationships with the health care team, adjustment to physical compromise, alterations in customary social support, isolationism, psychosocial reorientation, and employment and insurance problems.
CONCLUSIONS: The continuation of a rehabilitation effort begun around the initial diagnosis of cancer would be instrumental in providing post-therapy evaluation and guidance needed by adult long-term survivors of cancer. Education, research, and support interventions need to be mobilized for this population of adults with a history of cancer.

Entities:  

Mesh:

Year:  1989        PMID: 2672926     DOI: 10.7326/0003-4819-111-6-517

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  19 in total

1.  Surviving gynecologic cancer and coping with sexual morbidity: an international problem.

Authors:  B.L. Andersen; J. van Der Does
Journal:  Int J Gynecol Cancer       Date:  1994-07       Impact factor: 3.437

2.  The relationship between function, quality of life and coping in patients with low-grade gliomas.

Authors:  Margareta Gustafsson; Tanja Edvardsson; Gerd Ahlström
Journal:  Support Care Cancer       Date:  2006-05-19       Impact factor: 3.603

3.  Positive and negative psychosocial sequelae of bone marrow transplantation: implications for quality of life assessment.

Authors:  K Fromm; M A Andrykowski; J Hunt
Journal:  J Behav Med       Date:  1996-06

4.  Living post treatment: definitions of those with history and no history of cancer.

Authors:  Kimberly M Kelly; Neel Shah; Randi Shedlosky-Shoemaker; Kyle Porter; Doreen Agnese
Journal:  J Cancer Surviv       Date:  2011-01-15       Impact factor: 4.442

5.  Personal changes, dispositional optimism, and psychological adjustment to bone marrow transplantation.

Authors:  B Curbow; M R Somerfield; F Baker; J R Wingard; M W Legro
Journal:  J Behav Med       Date:  1993-10

Review 6.  Common psychiatric disorders in cancer patients. I. Adjustment disorders and depressive disorders.

Authors:  D Razavi; F Stiefel
Journal:  Support Care Cancer       Date:  1994-07       Impact factor: 3.603

Review 7.  Establishing comprehensive specialty follow-up clinics for long-term survivors of cancer. Providing systematic physiological and psychosocial support.

Authors:  P J Hollen; W L Hobbie
Journal:  Support Care Cancer       Date:  1995-01       Impact factor: 3.603

8.  A pilot study exploring the effect of discharging cancer survivors from hospital follow-up on the workload of general practitioners.

Authors:  I Chait; R Glynne-Jones; S Thomas
Journal:  Br J Gen Pract       Date:  1998-05       Impact factor: 5.386

9.  Quality of life in adult survivors of lung, colon and prostate cancer.

Authors:  C A Schag; P A Ganz; D S Wing; M S Sim; J J Lee
Journal:  Qual Life Res       Date:  1994-04       Impact factor: 4.147

10.  Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence.

Authors:  Sébastien Simard; Josée Savard
Journal:  Support Care Cancer       Date:  2008-04-15       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.